ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,474 | 57,225 | 69,600 | 37,126 | 51,349 |
| TOTAL | $50,191 | $58,026 | $70,544 | $38,139 | $52,487 |
| Non-Current Assets | |||||
| PPE Net | 884 | 861 | 855 | 1,133 | 813 |
| Investments And Advances | 3,414 | 3,406 | 3,406 | 3,406 | 3,406 |
| Other Non-Current Assets | 86 | 86 | 86 | 86 | 100 |
| TOTAL | $4,384 | $4,353 | $4,347 | $4,625 | $4,319 |
| Total Assets | $54,575 | $62,380 | $74,891 | $42,764 | $56,805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,282 | 3,151 | 6,042 | 6,349 | 8,504 |
| Accrued Expenses | 768 | 1,597 | 1,476 | 1,073 | 744 |
| TOTAL | $6,085 | $7,228 | $11,500 | $11,482 | $12,633 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,494 | 17,337 | 19,242 | 19,752 | 18,037 |
| TOTAL | $10,494 | $17,337 | $19,242 | $19,752 | $18,037 |
| Total Liabilities | $16,579 | $24,565 | $30,742 | $31,233 | $30,669 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,369 | 3,358 | 3,057 | 3,057 | 2,612 |
| Common Shares | 265,500 | 255,055 | 254,740 | 209,388 | 209,017 |
| Retained earnings | -227,504 | -217,239 | -210,590 | -197,857 | -182,881 |
| TOTAL | $37,996 | $37,815 | $44,149 | $11,531 | $26,136 |
| Total Liabilities And Equity | $54,575 | $62,380 | $74,891 | $42,764 | $56,805 |